MetaCap

CryoPort (CYRX) vs Latigo Biotherapeutics (LTGO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CryoPort is the larger company by market cap ($964.9 million vs $861.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CYRX+25.99%LTGO-28.77%
+41%+3%-34%
Aug 7, 20261 yearNov 20, 2026
CYRX+25.99%LTGO-28.77%
+36%+1%-34%
Aug 3, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CYRX versus LTGO key metrics
MetricCYRXLTGO
Share price$19.05$13.00
Market cap$964.87M$861.89M
1-day change-2.56%-1.81%
YTD return+98.44%—
1-year return+116.97%—
5-year return-71.38%—
EPS (TTM)$-0.90$-6.07
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$176.18M—
Revenue growth (YoY)+12.38%—
Net income (latest FY)$78.30M—
Gross margin47.14%—
Operating margin-20.89%—
Net margin44.44%—
52-week high$21.78$25.93
52-week low$7.61$10.24
Distance from 52-week high-12.53%-49.87%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+17.22%+301.92%
Average volume843.80K309.60K
Shares outstanding50.65M66.30M
Employees68466
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About CryoPort

CYRX stock →

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees

About Latigo Biotherapeutics

LTGO stock →

Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.

Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees

CYRX vs LTGO FAQ

Which is bigger, CryoPort or Latigo Biotherapeutics?

CryoPort (CYRX) is larger, with a market capitalization of $964.87M compared with $861.89M for Latigo Biotherapeutics (LTGO).

Are CryoPort and Latigo Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons